Covestro (ETR:1COV) Stock Price Up 0.1% - Still a Buy?

Key Points

• Covestro AG's stock rose 0.1% on Tuesday, closing at €59.32 ($68.98), but trading volume saw a significant drop of 98% compared to its average.
• The company has a market capitalization of $11.20 billion and a negative PE ratio of -34.29, indicating potential financial challenges.
• Covestro specializes in high-tech polymer materials with applications across various industries, including automotive and construction, through its segments of Performance Materials and Solutions & Specialties.

Covestro AG (ETR:1COV - ) shares rose 0.1% during trading on Tuesday . The company traded as high as €59.32 ($68.98) and last traded at €59.32 ($68.98). Approximately 13,843 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 917,794 shares. The stock had previously closed at €59.28 ($68.93).

Covestro Price Performance

The stock has a market cap of $11.20 billion, a PE ratio of -34.29, a P/E/G ratio of 0.51 and a beta of 1.17. The company has a debt-to-equity ratio of 55.84, a current ratio of 1.71 and a quick ratio of 0.85. The business has a fifty day moving average of €58.88 and a 200 day moving average of €59.35.

About Covestro

Covestro AG supplies high-tech polymer materials and application solutions. It operates in two segments, Performance Materials, and Solutions & Specialties. The Performance Materials segment develops, produces, and supplies high-performance materials, such as polyurethanes and polycarbonates, and base chemicals, which include diphenylmethane diisocyanate (MDI), toluylene diisocyanate, long-chain polyols, and polycarbonate resins for use in furniture and wood processing, construction, automotive, and transportation industries, as well as roof structures, insulation for buildings and refrigerators, mattresses, car seats, and other applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.